Trials / Completed
CompletedNCT00522275
Determine Safety and Efficacy of Long-term Oral Lacosamide in Patients With Partial Seizures
An Open-label Extension Trial to Determine Safety and Efficacy of Long-term Oral SPM 927 in Patients With Partial Seizures
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 308 (actual)
- Sponsor
- UCB BIOSCIENCES, Inc. · Industry
- Sex
- All
- Age
- 16 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this trial is to determine whether lacosamide is safe and effective for long-term use in patients with partial-seizures from epilepsy
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | lacosamide | 50mg or 100 mg tablets, up to 800 mg/day given twice daily (BID) throughout the trial |
Timeline
- Start date
- 2004-10-01
- Primary completion
- 2009-10-01
- Completion
- 2009-10-01
- First posted
- 2007-08-29
- Last updated
- 2018-07-18
- Results posted
- 2010-11-22
Locations
60 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00522275. Inclusion in this directory is not an endorsement.